FAM179B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.63650000001492E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.99000000039784E-07 |
Normal-vs-Stage2 |
8.210000E-04 |
Normal-vs-Stage3 |
3.301700E-03 |
Normal-vs-Stage4 |
4.81149999997932E-06 |
Stage1-vs-Stage2 |
9.294200E-01 |
Stage1-vs-Stage3 |
8.837400E-01 |
Stage1-vs-Stage4 |
3.012000E-01 |
Stage2-vs-Stage3 |
9.724800E-01 |
Stage2-vs-Stage4 |
2.522800E-01 |
Stage3-vs-Stage4 |
2.009400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.56009999988605E-07 |
Normal-vs-AfricanAmerican |
1.68231999999602E-05 |
Normal-vs-Asian |
2.300400E-03 |
Caucasian-vs-AfricanAmerican |
8.093000E-01 |
Caucasian-vs-Asian |
7.020800E-01 |
AfricanAmerican-vs-Asian |
7.378000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.7004999953183E-08 |
Normal-vs-Female |
9.983300E-03 |
Male-vs-Female |
4.814000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.373000E-04 |
Normal-vs-Extreme_Weight |
4.2020000035059E-08 |
Normal-vs-Obese |
7.379800E-04 |
Normal-vs-Extreme_Obese |
1.082420E-03 |
Normal_Weight-vs-Extreme_Weight |
3.312200E-01 |
Normal_Weight-vs-Obese |
4.717400E-01 |
Normal_Weight-vs-Extreme_Obese |
7.284000E-01 |
Extreme_Weight-vs-Obese |
4.917500E-02 |
Extreme_Weight-vs-Extreme_Obese |
8.461800E-01 |
Obese-vs-Extreme_Obese |
4.113800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.100900E-03 |
Normal-vs-Age(41-60Yrs) |
6.237100E-04 |
Normal-vs-Age(61-80Yrs) |
1.54170000099541E-08 |
Normal-vs-Age(81-100Yrs) |
1.70950000000225E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.940400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.359200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.134850E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.071700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.414030E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.002600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.4603000000335E-06 |
Normal-VS-Type2 PRCC |
1.05909999992271E-07 |
Normal-VS-KIRP CIMP |
5.694200E-02 |
Normal-VS-Unclassified PRCC |
3.069600E-02 |
Type1 PRCC-VS-Type2 PRCC |
1.278810E-01 |
Type1 PRCC-VS-KIRP CIMP |
5.986400E-01 |
Type1 PRCC-VS-Unclassified PRCC |
5.436600E-01 |
Type2 PRCC-VS-KIRP CIMP |
8.984800E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.685780E-01 |
KIRP CIMP-VS-Unclassified PRCC |
5.098000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.09650002597806E-09 |
Normal-vs-N1 |
6.276300E-03 |
Normal-vs-N2 |
3.77480000000041E-05 |
N0-vs-N1 |
2.174800E-01 |
N0-vs-N2 |
1.735170E-01 |
N1-vs-N2 |
1.358420E-01 |
|
|